If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Fortrea Holdings Inc. (FTRE) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Fortrea Holdings Inc. (FTRE) or Acadia Pharmaceuticals (ACAD). But which of these two companies is the best option for those looking for undervalued stocks?
Fortrea Holdings Inc. (FTRE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Fortrea Holdings Inc. (FTRE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Fortrea Holdings Inc. ( FTRE ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Tracy Krumme - Senior VP of Investor Relations Anshul Thakral - CEO & Director Jill McConnell - Chief Financial Officer Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division David Windley - Jefferies LLC, Research Division Luke Sergott - Barclays Bank PLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Jenny Cao - Truist Securities, Inc., Research Division Alan Chen Presentation Operator Good day, and thank you for standing by.
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.23 per share a year ago.
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Anshul Thakral - Corporate Participant Hima B. Inguva - Head of Investor Relations & Corporate Development Jill McConnell - Chief Financial Officer Peter M.
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.03 per share a year ago.
Fortrea Holdings Inc.'s operational and financial performance has deteriorated further, with missed improvement targets, declining sales, and mounting losses driving a 90% share price collapse. The company faces high leverage, negative earnings, and failed margin expansion, with debt restructuring and operational turnaround now critical for survival. Recent management changes and a shareholder rights plan signal efforts to protect FTRE investors amid takeover risks and ongoing business uncertainty.
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and Illumina (ILMN). But which of these two stocks offers value investors a better bang for their buck right now?
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q1 2025 Earnings Conference Call May 12, 2025 9:00 AM ET Company Participants Hima Inguva - Head, Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Peter Neupert - Chairman and Interim CEO Conference Call Participants David Windley - Jefferies Justin Bowers - DB Patrick Donnelly - Citi Eric Coldwell - Baird Elizabeth Anderson - Evercore Charles Rhyee - TD Cowen Luke Sergott - Barclays Matt Sykes - Goldman Sachs Max Smock - William Blair Michael Ryskin - Bank of America Operator Ladies and gentlemen, thank you for standing by. And welcome to Fortrea First Quarter 2025 Earnings Conference Call.
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.04 per share a year ago.